我院2005～2007年抗栓药应用分析

目的：了解我院抗栓药的应用现状，为临床合理用药提供参考。方法：采用频度分析和金额排序的方法对我院2005～2007年抗栓药应用情况进行分析。结果：我院抗栓药消耗金额占用药总金额的11．93％～18．21％、年增长率大于50％。氯吡格雷片和低分子肝素消耗金额之和分别占总金额的79．03％、81．15％、85．06％，消耗金额排序靠前还有华法林钠片、阿司匹林肠溶片、肝素钠针；阿司匹林肠溶片DDDs2006年和2007年均排序第1位，华法林钠、氯吡格雷片DDDs排序靠前；抗血小板药和抗凝药是抗栓药中的绝对主体。结论：抗栓药在心脏病专科有非常重要地位，市场前景广阔，防治血栓抗栓药有不可替代的作用，但更需要合理规范使用。

Analysis of the Use of Antithrombotic Agents in Our Hospital During the Period 2005 ～ 2007

OBJECTIVE ： To investigate the utilization of antithrombotic agents for reference of clinical rational drug use. METHODS ： The order of DDDs and consumption sum of antithrombotic agents in our hospital during the period 2005 - 2007 were analyzed. RESULTS：The antithrombotic agents used in our hospital accounted for 11.93% - 18.21% of total drugs in terms of consumptive sum, with an annual incremental rate of greater than 50 %. The consumption sum of Warfarin Sodium tablets plus low molecular weight heparin sodium occupied 79. 03%, 81.15%, 85.06% of total over the 3 years respectively. Warfarin Sdium tablets, Aspirin enteric-coated tablets and Heparin Sodium injection also took the lead on the list of consumption sum. Aspirin enteric-coated tablets occupied the first place in DDDs in both 2006 and 2007. Warfarin Sodium tablets and Clopidogrel Hydrogen Sulphate tablets ranked the front places in terms of DDDs. Anticoagulant drugs and antiplatelet drugs assumed a predominant position among all the antithrombotic agents. CONCLUSION：Antithrombotic agents occupied an important position in the special hospital of heart disease, which enjoy a promising prospect and play an irreplaceable role in the prevention and treatment of thrombotic diseases, but which should be used rationally.